By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TrovaGene, Inc. 

420 Lexington Avenue
Suite 170
New York  New York  10170  U.S.A.
Phone: n/a Fax: n/a



Company News
Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins TrovaGene, Inc.'s Scientific Advisory Board 8/12/2014 9:19:45 AM
TrovaGene, Inc. Announces Second Quarter 2014 Financial Results 8/8/2014 8:06:14 AM
TrovaGene, Inc. Schedules Release of Second Quarter 2014 Financial Results and Investor Conference Call 7/30/2014 9:33:13 AM
TrovaGene, Inc. Secures $15 Million In Debt Financing From Trojantec Ltd. And Oxford Finance 7/1/2014 10:21:12 AM
TrovaGene, Inc. Enters Into A Strategic Alliance With The Robert H. Lurie Comprehensive Cancer Center Of Northwestern University And The Northwestern Medicine Developmental Therapeutics Institute 6/30/2014 8:54:55 AM
TrovaGene, Inc. Announces Clinical Collaboration With Dana-Farber Cancer Institute 6/16/2014 7:02:25 AM
TrovaGene, Inc. Release: Oncogene Mutation Signal In Urinary Cell Free DNA Is Highly Correlated With Treatment Response 6/3/2014 8:53:29 AM
TrovaGene, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 6:31:23 AM
TrovaGene, Inc.'s Precision Cancer Monitoring Technology Referenced In Multi-Disciplinary Clinical Consensus Guidelines 5/28/2014 9:16:26 AM
TrovaGene, Inc. Announces Publication Of Data From Clinical Validation Program Using Its Precision Cancer Monitoring Platform 5/20/2014 8:35:33 AM